Websites Hosted in dns3.novartis.com Nameserver
The Nameserver dns3.novartis.com have a IP Address of 160.62.14.115 which is hosted on United States of America.
AmLactin® Alpha Hydroxy skin care - Lotions for Rough, Dry Skin
The AmLactin® family of alpha-hydroxy lotions, creams and moisturizers gently exfoliate and moisturize, providing serious skin care for rough, dry skin.
2,206,225
$
480.00
Pill for Relapsing MS | RRMS Treatment | GILENYA (fingolimod)
GILENYA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults and children 10 years of age and older. This once-a-day pill helps cut MS relapses in half.
3,261,232
$
480.00
Home | EXJADE® (deferasirox) FILM-COATED TABLETS
Learn about EXJADE®, an iron chelation therapy for the management of chronic iron overload due to blood transfusions. See safety & product information.
9,205,258
$
240.00
FEMARA® (letrozole) | 1L Treatment for HR+ Metastatic Breast Cancer
Discover FEMARA® (letrozole), an approved treatment from Novartis Oncology for HR+ breast cancer in postmenopausal women. Learn about FEMARA® side effects & see recommended FEMARA® dosage information.
Not Applicable
$
8.95
TYKERB® (lapatinib) | HR+, HER2+ Metastatic Breast Cancer
Learn about TYKERB® (lapatinib), approved to treat HR+ and HER2+ metastatic breast cancer. Find Important Safety Information and BOXED WARNING.
5,943,198
$
240.00
AFINITOR® (everolimus) | Official Site from Novartis
The official website for AFINITOR® (everolimus) tablets. Find information about AFINITOR®, the conditions it treats, and Important Safety Information.
2,946,082
$
480.00
Spotlight on MPN: Patient & Professional Resources on the Diagnosis, T
Please select Patient/Caregiver or Healthcare Professional to access information and resources targeted to the diagnosis, treatment and management of Myelofibrosis (MF), Polycythaemia Vera (PV) & Essential Thrombocythaemia (ET).
Not Applicable
$
8.95
PIQRAY® (alpelisib) Access & Patient Assistance | HCP
Learn about the PIQRAY® free trial program and universal co-pay card to help patients save on out-of-pocket costs. See full Prescribing and Safety Info.
Not Applicable
$
8.95
Safety of Beovu® (brolucizumab)
Novartis provides update on use and safety of Beovu® (brolucizumab)
Not Applicable
$
8.95
Understanding MET in NSCLC
Learn about non-small cell lung cancer (NSCLC) and how it is impacted by oncogenes, MET dysregulation, and the METex14 subtype.
Not Applicable
$
8.95
Understanding MET in NSCLC
Learn about non-small cell lung cancer (NSCLC) and how it is impacted by oncogenes, MET dysregulation, and the METex14 subtype.
Not Applicable
$
8.95
ADAKVEO (crizanlizumab) | Now Approved
Find patient information about ADAKVEO (crizanlizumab), now approved. See full Safety & Prescribing Information.
Not Applicable
$
8.95
ADAKVEO (crizanlizumab) | Now Approved
Find HCP information, including prescribing information, for ADAKVEO (crizanlizumab), now approved.
Not Applicable
$
8.95
ADAKVEO (crizanlizumab) | Now Approved
Find HCP information, including prescribing information, for ADAKVEO (crizanlizumab), now approved.
Not Applicable
$
8.95
RYDAPT® (midostaurin) | AML and ASM Treatment
Learn about RYDAPT treatment for FLT3-positive acute myeloid leukemia (AML) and 3 types of systemic mastocytosis (SM). See full Prescribing & Safety Info.
Not Applicable
$
8.95
Eye Allergy Itch Relief | PAZEODrops.com
PAZEO® Solution provides 24-hour eye allergy itch relief with one drop daily. Learn more and get savings on Pazeo® Solution.
Not Applicable
$
8.95
